XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:        
Total revenue $ 12,451 $ 13,194 $ 36,697 $ 40,365
Expenses:        
Research and development (1) 9,867 43,739 48,691 162,431
Selling, general and administrative (1) 16,277 21,299 51,105 77,780
Restructuring and related expenses (1) 509 1,771 11,427 1,771
Total expenses 26,653 66,809 111,223 241,982
Loss from operations (14,202) (53,615) (74,526) (201,617)
Interest expense (1,545) (2,136) (5,819) (6,410)
Loss on extinguishment of debt (3,034)   (3,034)  
Interest income and other income (expense), net 2,758 (166) 4,823 771
Loss from continuing operations before income taxes (16,023) (55,917) (78,556) (207,256)
Provision for income tax benefit (expense)   7 (12)  
Net loss from continuing operations (16,023) (55,910) (78,568) (207,256)
Income from discontinued operations before income taxes 1,115,016 20,602 1,143,930 39,864
Provision for income tax expense (182,362)   (182,868)  
Net income from discontinued operations 932,654 20,602 961,062 39,864
Net income (loss) 916,631 (35,308) 882,494 (167,392)
Net unrealized gain (loss) on available-for-sale investments (76) 6 (121) (33)
Total comprehensive income (loss) $ 916,555 $ (35,302) $ 882,373 $ (167,425)
Net income (loss) per share:        
Continuing operations - basic $ (0.21) $ (0.76) $ (1.04) $ (3.05)
Continuing operations - diluted (0.21) (0.76) (1.04) (3.05)
Discontinued operations - basic 12.35 0.28 12.70 0.59
Discontinued operations - diluted 12.35 0.28 12.70 0.59
Net income (loss) - basis 12.14 (0.48) 11.66 (2.46)
Net income (loss) - diluted $ 12.14 $ (0.48) $ 11.66 $ (2.46)
Shares used to compute basic net income (loss) per share 75,515 73,574 75,678 67,945
Shares used to compute diluted net income (loss) per share 75,515 73,574 75,678 67,945
Total share-based compensation expense $ 8,530 $ 14,370 $ 32,784 $ 45,143
Research and development        
Expenses:        
Restructuring and related expenses (1) 100   5,300  
Net income (loss) per share:        
Total share-based compensation expense 2,623 6,956 10,709 22,192
Selling, general and administrative        
Expenses:        
Restructuring and related expenses (1) 400   6,200  
Net income (loss) per share:        
Total share-based compensation expense 5,196 7,414 16,488 22,951
Restructuring and related expenses        
Net income (loss) per share:        
Total share-based compensation expense 711   5,587  
Viatris collaboration agreement        
Revenue:        
Total revenue 12,445 10,397 34,010 31,716
Collaboration revenue        
Revenue:        
Total revenue $ 6 $ 2,797 187 $ 8,649
Licensing revenue        
Revenue:        
Total revenue     $ 2,500